Skip to content
PatentBrief
Get alertsTop ↑

How a Droplet Device Delivers Medicine When You Breathe In

This patent describes an electronic device that sprays a fine mist of liquid, like medicine, into your mouth or nose automatically when it detects you are inhaling at a specific speed.

Granted 2026ActiveExpires 2045

Original patent title: “Droplet device actuation from inhalation sensing”

Plain-English explanation by SahiLast reviewed · October 2, 2026

This patent describes an electronic device that sprays a fine mist of liquid, like medicine, into your mouth or nose automatically when it detects you are inhaling at a specific speed. Granted in 2026.

Coverage

What does this patent actually cover?

This electronic droplet delivery device includes a main body, called a housing, with a mouthpiece for air to exit. It holds liquid in a removable fluid reservoir. Inside, an aperture plate with many small openings receives fluid from this reservoir. An electronic actuator then vibrates this aperture plate very quickly, which creates a stream of tiny droplets. A sensor in the device is connected to this actuator and is designed to trigger the droplet stream only when it senses a specific, pre-set breathing speed, or "predetermined inhalation flow rate," from the user.

The gap

What does this patent NOT cover?

  • Does not cover devices that are triggered by a manual button press or a timer, rather than by sensing inhalation.
  • Does not cover devices that use propellants or heat to create a mist, as it specifies an "electronic actuator that oscillates the aperture plate."
  • Does not cover devices that deliver a continuous stream of liquid instead of an "ejected stream of droplets."
  • Does not cover devices that deliver liquid without first detecting a "predetermined inhalation flow rate."
  • Does not cover devices that do not include a "removable fluid reservoir" or an "aperture plate."

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 12734312
StatusActive
FieldConsumer Electronics
Filed2025
Granted2026
Times cited0
LitigationNone on record
Value · $26K–$84KMinimal

What made this novel

The innovation lies in precisely coordinating the release of medicine with the user's breathing, specifically by detecting a "predetermined inhalation flow rate." This ensures the droplets are delivered deep into the lungs or nasal passages at the most effective time, overcoming common challenges with user coordination in traditional inhalers.

Droplet device actuation from …(Primary claim)consumer electronicsbiotechsoftwaretelecommunications

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Smart inhalers for asthma and COPD

02

Electronic nebulizers with breath-actuated features

03

Connected drug delivery devices for respiratory therapy

Why it matters

The bigger picture

This technology aims to improve how effectively people receive inhaled medicines by ensuring the medicine is delivered at the optimal moment during breathing. By automatically triggering droplet delivery only when a user inhales correctly, it can help patients, especially children or those with coordination difficulties, get the full benefit of their medication. This can lead to better health outcomes and more consistent treatment adherence for respiratory conditions.

Filed

February 13, 2025

Granted

September 15, 2026

Market context

Who's building on this

Companies in this space

Companies in the respiratory drug delivery space, such as AstraZeneca, GSK, and Philips, are actively developing and marketing smart inhaler technologies. Startups like Propeller Health also focus on connected health solutions for respiratory conditions, often integrating sensors to monitor and improve medication adherence and technique.

Market impact

This type of technology contributes to the growing market for 'smart' medical devices, particularly in respiratory care. It enables more precise and effective drug delivery, potentially reducing medication waste and improving patient outcomes. The focus on inhalation sensing supports the development of devices that can collect data on patient usage, which can be valuable for healthcare providers in managing chronic conditions.

Claim 1 — Plain English

What this patent covers

This electronic droplet delivery device includes a main body, called a housing, with a mouthpiece for air to exit. It holds liquid in a removable fluid reservoir. Inside, an aperture plate with many small openings receives fluid from this reservoir. An electronic actuator then vibrates this aperture plate very quickly, which creates a stream of tiny droplets. A sensor in the device is connected to this actuator and is designed to trigger the droplet stream only when it senses a specific, pre-set breathing speed, or "predetermined inhalation flow rate," from the user.

The clever bit

The innovation lies in precisely coordinating the release of medicine with the user's breathing, specifically by detecting a "predetermined inhalation flow rate." This ensures the droplets are delivered deep into the lungs or nasal passages at the most effective time, overcoming common challenges with user coordination in traditional inhalers.

What it does not cover

  • Does not cover devices that are triggered by a manual button press or a timer, rather than by sensing inhalation.
  • Does not cover devices that use propellants or heat to create a mist, as it specifies an "electronic actuator that oscillates the aperture plate."
  • Does not cover devices that deliver a continuous stream of liquid instead of an "ejected stream of droplets."
  • Does not cover devices that deliver liquid without first detecting a "predetermined inhalation flow rate."
  • Does not cover devices that do not include a "removable fluid reservoir" or an "aperture plate."

Patent timeline

Filing

Application submitted to the patent office

Grant

Patent officially issued

PatentBrief Score

Impact Score

Early stage

Citation count

0/40

No citations yet

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

20/20

Granted within 5 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$26K – $84K

Midpoint $53K · 18.4 yr remaining · industry ×2.2

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Cite this patent

(2026). How a Droplet Device Delivers Medicine When You Breathe In (U.S. Patent No. 12,734,312). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12734312/droplet-device-actuation-from-inhalation-sensing

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US12734312"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

More to explore

More in Consumer Electronics

Browse all Consumer Electronics

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverConsumer Electronics PatentsPatent glossary
Explore the landscape:consumer electronics patents →biotech patents →software patents →

Common Questions

Frequently Asked Questions

What does How a Droplet Device Delivers Medicine When You Breathe In cover?

This patent describes an electronic device that sprays a fine mist of liquid, like medicine, into your mouth or nose automatically when it detects you are inhaling at a specific speed.

When does this patent expire?

This patent is expected to expire on September 15, 2046, when the invention enters the public domain.

What problem does this patent solve?

This technology aims to improve how effectively people receive inhaled medicines by ensuring the medicine is delivered at the optimal moment during breathing. By automatically triggering droplet delivery only when a user inhales correctly, it can help patients, especially children or those with coordination difficulties, get the full benefit of their medication. This can lead to better health outcomes and more consistent treatment adherence for respiratory conditions.

What does this patent NOT cover?

Does not cover devices that are triggered by a manual button press or a timer, rather than by sensing inhalation.

Patent monitoring

Get notified when new matching patents are published

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: October 2, 2026 · PatentBrief is not a law firm and this is not legal advice.